[Axitinib in metastatic renal carcinomas: update of knowledge about side effects].

Author: AlbigesLaurence, BoyleHelen, EderhyStéphane, EscudierBernard, GravisGwenaëlle, HartlDana, IzzedineHassan, RobertCaroline, ScottéFlorian

Paper Details 
Original Abstract of the Article :
PURPOSE: The objective of this article is to summarize the knowledge as for the side effects related to axitinib in terms of incidence, etiology and symptoms for the effects requiring a specific management. METHODS: This article follows upon the recommendations for the clinical practice, published ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1684/bdc.2014.2042

データ提供:米国国立医学図書館(NLM)

Axitinib for Metastatic Renal Cell Carcinoma: Understanding the Side Effects

Metastatic renal cell carcinoma is like a relentless sandstorm, spreading through the body and threatening to engulf the patient. This study examines the side effects of axitinib, a targeted therapy used to combat this aggressive cancer. It's like navigating a delicate balance between attacking the storm and minimizing collateral damage.

A Promising Targeted Therapy with a Favorable Side Effect Profile

The study found that axitinib has a better toxicity profile than other tyrosine kinase inhibitors, offering a glimmer of hope for patients facing this challenging condition. It's like finding a more gentle camel that can carry you through the desert without causing too much discomfort. The authors highlight the need for ongoing management and follow-up of side effects, emphasizing the importance of vigilance and timely intervention.

Navigating the Desert of Metastatic Cancer

This study offers valuable insights into the side effects of axitinib, helping patients and healthcare providers navigate the complex terrain of metastatic renal cell carcinoma. It's a reminder that even with promising new therapies, careful monitoring and management are essential to ensure the best possible outcomes.

Dr.Camel's Conclusion

This study provides important information about the side effects of axitinib, offering a nuanced perspective on this targeted therapy for metastatic renal cell carcinoma. It's a reminder that finding the right treatment is a delicate balance between attacking the storm and minimizing collateral damage, requiring careful navigation and vigilance throughout the journey.
Date :
  1. Date Completed 2015-03-25
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

25373697

DOI: Digital Object Identifier

10.1684/bdc.2014.2042

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

French

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.